Science 37® and 3H Medi Solution Collaborate to Enable Decentralized Clinical Trials in Japan and Accelerate Patient Enrollment
October 27 2021 - 7:55AM
Science 37, the Operating System for today’s more agile clinical
trials and 3H Medi Solution Inc., a clinical trials solution leader
in Japan today announced a collaboration to further decentralized
clinical trials and accelerate the development of therapies. In
this partnership, 3H Medi Solution will use Science 37’s clinical
trial Operating System with its end-to-end technology platform for
eConsent, electronic data capture, patient management, telemedicine
and mobile nurse operations.
With a traditional site-based drug development model,
biopharmaceutical sponsors are limited by geography and physical
location, making it difficult for patients to participate.
Decentralized trials, enabled by digital technology, can alleviate
these burdens—helping to drive efficiency, reduce costs and bring
trials which offer potentially life-saving treatments, closer to
patients.
“This collaboration will pave the way for promoting
decentralized clinical trials in Japan which is long overdue. It
will help to reduce the patient burden, broaden the option for
clinical trial participation and speed drug development for the
Japanese market.” said Sho Ando, Representative Director and
President at 3H Medi Solution. “By partnering with Science 37 and
utilizing their Operating System, we are able to complement and
create synergy while bringing research closer to patients—helping
to optimize the decentralized trials paradigm, and developing a
more patient-centric model.”
Through this partnership, 3H Medi Solution becomes part of the
Science 37 CRO Certified network, designed to empower CROs with
access, training, and commercial support to successfully deliver
decentralized clinical studies at scale.
“Working with 3H Medi Solution aligns with our mission to
accelerate research and enable patient and provider access with one
of the leading services providers in Japan,” said David Coman,
Chief Executive Officer of Science 37. “Our Operating System will
empower 3H Medi Solution and enable access to our patient
communities, telemedicine investigators, remote coordinator and
connected device networks to harmonize and deliver studies.”
About 3H Medi SolutionAs a life science company
that connects human health and happiness, we provide one-stop
solutions starting from patient recruiting, patient surveys,
providing information, developing apps and systems, to supporting
new business development in the arena of medical and
pharmaceutical. We offer solutions for the patient and medical
issues by realizing drug discovery and drug development support
based on science and Patient Centricity and digital health
transformation utilizing the latest technology. For more details
pls visit our homepage https://global-3h.com/.
About Science 37Science 37, Inc.’s mission is to enable
universal access to clinical research—making it easier for patients
and providers to participate from anywhere and helping to
accelerate the development of treatments that impact patient lives.
As a pioneer of decentralized clinical trials, the Science 37
Clinical Trial Operating System (OS) supports today’s more agile
clinical research designs with its full stack, end-to-end
technology platform and specialized networks of patient
communities, telemedicine investigators, mobile nurses, remote
coordinators and connected devices. Configurable to enable any
study type, the Science 37 OS enables up to 15x faster enrollment,
28% better retention and 3x more diverse patient population with
industry-leading workflow orchestration, evidence generation and
data harmonization. For more information, visit
https://www.science37.com.
MEDIA INQUIRIES:
3H Medi Solution:Ken Nomura Public Relations
group, 3H Holdingspressroom@3h-holdings.co.jp
Mohammad ImranGlobal Business Development Head, 3H Medi
Solutionimran@3h-ms.co.jp+81-3- 5953-2108
Science 37: Margie
KoomanMargie.Kooman@science37.comScience 37984. 377.3737
INVESTOR RELATIONS:Caroline PaulGilmartin
GroupInvestors@science37.com
Science 37 (NASDAQ:SNCE)
Historical Stock Chart
From Jun 2024 to Jul 2024
Science 37 (NASDAQ:SNCE)
Historical Stock Chart
From Jul 2023 to Jul 2024